Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fertility-sparing Treatment Strategy in Early Cervical Cancer
NCT02624531Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2015
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisplatin in Cervical Cancer (CC), sponsored by Sun Yat-sen University. Primary endpoint: Pregnancy Rate at 5 years. Status: unknown.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02624531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624531.